Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1-Reference-Cited by-同舟云学术

Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1

Published:2008-04 Issue:1-3 Volume:101 Page:273-286
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

Meyer Jonathan M.,Davis Vicki G.,Goff Donald C.,McEvoy Joseph P.,Nasrallah Henry A.,Davis Sonia M.,Rosenheck Robert A.,Daumit Gail L.,Hsiao John,Swartz Marvin S.,Stroup T. Scott,Lieberman Jeffrey A.

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference46 articles.

1. Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation;Alberti;Diabetic Medicine,2006

2. Diagnosis and classification of diabetes mellitus;American Diabetes Association;Diabetes Care,2007

3. Consensus development conference on antipsychotic drugs and obesity and diabetes;American Diabetes Association;Journal of Clinical Psychiatry,2004

4. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary;American Heart Association;Cardiology in Review,2005

5. Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations;Assmann;American Journal of Cardiology,2007

Cited by 230 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic Syndrome and Its Associated Factors Among Patients With Schizophrenia Treated With Second-Generation Antipsychotics at Amanuel Mental Specialized Hospital, Ethiopia;Cureus;2024-09-10

2. Sex Differences Between Female and Male Individuals in Antipsychotic Efficacy and Adverse Effects in the Treatment of Schizophrenia;CNS Drugs;2024-05-07

3. Metabolic Syndrome and Lifestyle Factors in Patients with Schizophrenia: A Cross-Sectional Hospital-Based Study;Annals of Indian Psychiatry;2024-02-26

4. Prevalence and risk factors for metabolic syndrome in schizophrenia, schizoaffective, and bipolar disorder;International Journal of Psychiatry in Clinical Practice;2024-02-08

5. Community Pharmacists’ Role in Reducing the Incidence of Cardiometabolic Adverse Drug Events in Schizophrenia: Insights from Mental Health Professionals;Medicina;2023-11-21